Cargando…

Vildagliptin reduces plasma stromal cell‐derived factor‐1α in patients with type 2 diabetes compared with glimepiride

AIMS/INTRODUCTION: Dipeptidyl peptidase‐4 inhibitors might have pleiotropic protective effects on cardiovascular disease (CVD), in contrast to sulfonylureas. Therefore, we compared various CVD risk factors between vildagliptin and glimepiride. MATERIALS AND METHODS: We carried out a randomized, pros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Kyeong Seon, Kwak, SooHeon, Cho, Young Min, Park, Kyong Soo, Jang, Hak C, Kim, Seong Yeon, Jung, Hye Seung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334315/ https://www.ncbi.nlm.nih.gov/pubmed/27575011 http://dx.doi.org/10.1111/jdi.12572

Ejemplares similares

Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
por: Jeon, Hyun Jeong, et al.
Publicado: (2011)

Higher Risk of Hypoglycemia with Glimepiride Versus Vildagliptin in Patients with Type 2 Diabetes is not Driven by High Doses of Glimepiride: Divergent Patient Susceptibilities?
por: Ahrén, Bo, et al.
Publicado: (2014)

1,5-Anhydro-D-Glucitol Could Reflect Hypoglycemia Risk in Patients with Type 2 Diabetes Receiving Insulin Therapy
por: Kim, Min Kyeong, et al.
Publicado: (2016)

Serum bilirubin levels are positively associated with glycemic variability in women with type 2 diabetes
por: Kim, Lee Kyung, et al.
Publicado: (2016)

Identification of Two Cases of Ciliopathy-Associated Diabetes and Their Mutation Analysis Using Whole Exome Sequencing
por: Kim, Min Kyeong, et al.
Publicado: (2015)

Finding Genetic Risk Factors of Gestational Diabetes
por: Kwak, Soo Heon, et al.
Publicado: (2012)

Comparison of Safety and Efficacy of Glimepiride-Metformin and Vildagliptin- Metformin Treatment in Newly Diagnosed Type 2 Diabetic Patients
por: Kumar, Surendra
Publicado: (2021)

Retinoid X Receptor α Overexpression Alleviates Mitochondrial Dysfunction-induced Insulin Resistance through Transcriptional Regulation of Insulin Receptor Substrate 1
por: Lee, Seung Eun, et al.
Publicado: (2015)

Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece
por: Kousoulakou, Hara, et al.
Publicado: (2017)

F-box only protein 9 is an E3 ubiquitin ligase of PPARγ
por: Lee, Kyeong Won, et al.
Publicado: (2016)

Feasibility of a Patient-Centered, Smartphone-Based, Diabetes Care System: A Pilot Study
por: Kim, Eun Ky, et al.
Publicado: (2016)

Clinical Characteristics of Subjects with Sulfonylurea-Dependent Type 2 Diabetes
por: Min, Se Hee, et al.
Publicado: (2015)

Gender Differences in Diagnostic Values of Visceral Fat Area and Waist Circumference for Predicting Metabolic Syndrome in Koreans
por: Kim, Hong Il, et al.
Publicado: (2011)

Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
por: Ahrén, Bo, et al.
Publicado: (2010)

Normal Glucose Tolerance with a High 1-Hour Postload Plasma Glucose Level Exhibits Decreased β-Cell Function Similar to Impaired Glucose Tolerance
por: Oh, Tae Jung, et al.
Publicado: (2015)

Clinical Characteristics of the Responders to Dipeptidyl Peptidase-4 Inhibitors in Korean Subjects with Type 2 Diabetes
por: Oh, Tae Jung, et al.
Publicado: (2013)

Genome-Wide Association Study on Longitudinal Change in Fasting Plasma Glucose in Korean Population
por: Jin, Heejin, et al.
Publicado: (2023)

Genetic Studies on Diabetic Microvascular Complications: Focusing on Genome-Wide Association Studies
por: Kwak, Soo Heon, et al.
Publicado: (2015)

Pathophysiology of Type 2 Diabetes in Koreans
por: Kwak, Soo Heon, et al.
Publicado: (2018)

Recent progress in genetic and epigenetic research on type 2 diabetes
por: Kwak, Soo Heon, et al.
Publicado: (2016)

Comparison of Prevailing Insulin Regimens at Different Time Periods in Hospitalized Patients: A Real-World Experience from a Tertiary Hospital
por: Moon, Sun Joon, et al.
Publicado: (2022)

Response: Normal Glucose Tolerance with a High 1-Hour Postload Plasma Glucose Level Exhibits Decreased β-Cell Function Similar to Impaired Glucose Tolerance (Diabetes Metab J 2015;39:147-53)
por: Oh, Tae Jung, et al.
Publicado: (2015)

Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin
por: Kim, Jong Ho, et al.
Publicado: (2016)

A Genome-Wide Association Study of Gestational Diabetes Mellitus in Korean Women
por: Kwak, Soo Heon, et al.
Publicado: (2012)

Two Cases of Methimazole-Induced Insulin Autoimmune Syndrome in Graves' Disease
por: Roh, Eun, et al.
Publicado: (2013)

Metabolic syndrome independently predicts future diabetes in women with a history of gestational diabetes mellitus
por: Cho, Nam H., et al.
Publicado: (2016)

Ten Years of Vildagliptin
por: Del Prato, Stefano
Publicado: (2017)

Surfing the Vildagliptin Tsunami
por: Balachandran, Karthik
Publicado: (2020)

Update on Monogenic Diabetes in Korea
por: Yang, Ye Seul, et al.
Publicado: (2020)

Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects
por: Yoo, Hyounggyoon, et al.
Publicado: (2020)

Diagnostic Value of Galectin-3, HBME-1, Cytokeratin 19, High Molecular Weight Cytokeratin, Cyclin D1 and p27(kip1) in the Differential Diagnosis of Thyroid Nodules
por: Park, Young Joo, et al.
Publicado: (2007)

Subsequent Pregnancy After Gestational Diabetes Mellitus: Frequency and risk factors for recurrence in Korean women
por: Kwak, Soo Heon, et al.
Publicado: (2008)

Estimated Association Between Cytokines and the Progression to Diabetes: 10-year Follow-Up From a Community-Based Cohort
por: Cho, Nam H, et al.
Publicado: (2019)

Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea
por: Kim, Hye-soon, et al.
Publicado: (2014)

Increasing Prevalence of Metabolic Syndrome in Korea: The Korean National Health and Nutrition Examination Survey for 1998–2007
por: Lim, Soo, et al.
Publicado: (2011)

Carotid Intimal-Medial Thickness Is Not Increased in Women with Previous Gestational Diabetes Mellitus
por: Ku, Yun Hyi, et al.
Publicado: (2011)

Mitochondrial Complexes I and II Are More Susceptible to Autophagy Deficiency in Mouse β-Cells
por: Kim, Min Joo, et al.
Publicado: (2015)

Identification and Functional Characterization of P159L Mutation in HNF1B in a Family with Maturity-Onset Diabetes of the Young 5 (MODY5)
por: Kim, Eun Ky, et al.
Publicado: (2014)

Triglyceride-Glucose Index Predicts Future Atherosclerotic Cardiovascular Diseases: A 16-Year Follow-up in a Prospective, Community-Dwelling Cohort Study
por: Moon, Joon Ho, et al.
Publicado: (2023)

Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
por: Das, Sambit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5i9m4pv7irc80ajorladam4sis